Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness

Kardiol Pol. 2021 Mar 25;79(3):243-245. doi: 10.33963/KP.15889. Epub 2021 Mar 25.

Authors

Giuseppe Boriani¹, Anna C Valenti¹, Marco Vitolo^{1

2}

Affiliations

¹ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, italy
² Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, italy

PMID: 33779121
DOI: 10.33963/KP.15889

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation* / diagnosis
Biomarkers
Cost-Benefit Analysis
Electric Countershock
Humans
Obesity

Substances

Anticoagulants
Biomarkers